Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer Patients with locally advanced ...
Please provide your email address to receive an email when new articles are posted on . More than 70% of patients requesting assistance identified as African American. Patients who received assistance ...
Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide
Patient-reported outcomes (PROs) are being increasingly integrated into routine clinical practice to enhance individual patient care. This has been driven by recognition of the benefits of PROs in ...
Panelists discuss how patient-reported outcomes are crucial for capturing MS symptoms like fatigue, depression, and cognitive decline that significantly impact working-age patients but require ...
A large multinational clinical trial has found that giving healthcare providers access to European Organisation for Research and Treatment of Cancer (EORTC) patient-reported outcome (PRO) data ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. As part of our commitment, we've once again partnered with Statista, ...
The last draft guidance on using clinical outcomes assessments (COA) as endpoints in patient-focused drug development (PFDD) should use terminology more consistently, align more closely to other PFDD ...
The U.S. Food and Drug Administration (FDA) issued its third Patient-Focused Drug Development (PFDD) guidance titled, “Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results